SITC Session at TRCCC 27th Annual Meeting

When:  Feb 19, 2025 from 13:00 to 14:15 (ET)

Translational Research Cancer Centers Consortium

The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.

TRCCC was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. The organization has successfully brought together leaders in this field to advance science, collaboration, and clinical trials to help individuals diagnosed with cancer.

TRCCC 27th Meeting

The SITC Sponsored Session on Cell Therapy for Solid Tumor will take place on Wednesday, February 19th from 1-2:15 p.m.

TRCCC-SITC Collaboration Session “Cell Therapy for Solid Tumor” 

Agenda:

  1. Michael Lotze, MD, FACS - University of Pittsburgh Medical Center – “The Challenge, Approval and Future of TIL Therapy”
  2. Kristin Anderson, PhD - University of Virginia – “The Challenge, Approval and Future of TCR Gene Therapy”
  3. Marco Davila, MD, PhD - Roswell Park Comprehensive Cancer Center – “CAR T cells for Solid tumor - Breaking the glass ceiling”
  4. Daniel Powell, PhD - University of Pennsylvania – “On the horizon: Unconventional, sapient approaches”

Location

Seven Springs Resort
777 Water Wheel Dr
Champion, PA 15622